Dependent variable | Predictors | R | r2 | F | P value* | β | t | P value | VIF |
---|
IOP averagea | MDA (nmol/ml) | 0.40 | 0.13 | 4.49 | 0.002 | 0.29 | 2.86 | 0.005 | 1.17 |
AOPP (mmol/L) | | | | | −0.07 | −0.66 | 0.510 | 1.18 |
PC (nmol/ml) | | | | | 0.15 | 1.53 | 0.129 | 1.08 |
IMA (ABSU) | | | | | 0.18 | 1.84 | 0.07 | 1.09 |
IOP averageb | MDA (nmol/ml) | 0.50 | 0.25 | 4.83 | 0.002 | 0.34 | 2.80 | 0.007 | 1.11 |
AOPP (mmol/L) | | | | | −0.06 | −0.51 | 0.612 | 1.08 |
PC (nmol/ml) | | | | | 0.25 | 2.05 | 0.045 | 1.11 |
IMA (ABSU) | | | | | 0.21 | 1.78 | 0.08 | 1.04 |
- IOP intraocular pressure, β standardized coefficient, VIF variance inflation factor, MDA malondialdehyde, AOPP advanced oxidation protein products, IMA ischemia-modified albumin, ABSU absorbance units
- *P value obtained from ANOVA table
- aAll subjects (n=35 for control subjects, n=64 for PACG patients), bControl and PACG subjects after excluding subjects with DM, hypertension, CVD, and smoking (n= 26 for the control group and 36 for PACG patients)
- P < 0.05 was considered significant